Government approves Bharat Biotech's Ankleshwar plant to produce Covaxin
1/5
Approved
Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin.
"Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted.
"Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted.
2/5
Increasing availability
The approval would help increase availability of COVID-19 vaccines in the country, he added.
3/5
Minister tweets
"Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world's largest vaccine drive," the minister who heads both Chemicals and Fertilisers and Health ministries noted.
Amazon Top Deals
POWERED BY
atomberg Studio Smart+ 1200mm BLDC Ceiling Fan with IoT & Remote | BEE 5 star Rated Energy Efficient Ceiling Fan | High Air Delivery with LED Indicators | 3 Year Warranty (Earth Brown)
₹5,882Buy Now36%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹19,340Buy Now19%
OFF
4/5
Going ahead with plans
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility.
5/5
Adding another 200 million doses
The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.